Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
Inflammatory Bowel Diseases
|
August 5, 2004
Seeing red in inflammatory bowel disease: the eosinophil at center stage?
Philip B Miner
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 29, 2018
Irritable Bowel Syndrome Symptoms Following Giardiasis
Philip B Miner
Expert Opinion on Pharmacotherapy
|
August 22, 2018
Elobixibat, the first-in-class Ileal Bile Acid Transporter inhibitor, for the treatment of Chronic Idiopathic Constipation
Philip B Miner
Drug Safety
|
January 17, 2019
Benefit-Risk Assessment of Plecanatide in the Treatment of Chronic Idiopathic Constipation
Philip B Miner
Expert Review of Gastroenterology & Hepatology
|
January 28, 2020
Plecanatide for the treatment of constipation-predominant irritable bowel syndrome
Philip B Miner
The American Journal of Gastroenterology
|
November 8, 2017
Response to Currie et al
Philip B Miner
Expert Opinion on Pharmacotherapy
|
January 30, 2018
Efficacy and safety of plecanatide in treating constipation predominant irritable bowel syndrome
Philip B Miner
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 5, 2019
Effect of Treatment on the Risk of Viral Infections in Inflammatory Bowel Disease
Philip B Miner
Gastroenterology
|
February 24, 2004
Economic and personal impact of fecal and urinary incontinence
Philip B Miner
Gastrointestinal Endoscopy Clinics of North America
|
September 14, 2014
Evaluation of esophageal sensation
Salman Nusrat, Philip B Miner
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
Inflammatory Bowel Diseases
|
August 5, 2004
Seeing red in inflammatory bowel disease: the eosinophil at center stage?
Philip B Miner
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 29, 2018
Irritable Bowel Syndrome Symptoms Following Giardiasis
Philip B Miner
Expert Opinion on Pharmacotherapy
|
August 22, 2018
Elobixibat, the first-in-class Ileal Bile Acid Transporter inhibitor, for the treatment of Chronic Idiopathic Constipation
Philip B Miner
Drug Safety
|
January 17, 2019
Benefit-Risk Assessment of Plecanatide in the Treatment of Chronic Idiopathic Constipation
Philip B Miner
Expert Review of Gastroenterology & Hepatology
|
January 28, 2020
Plecanatide for the treatment of constipation-predominant irritable bowel syndrome
Philip B Miner
The American Journal of Gastroenterology
|
November 8, 2017
Response to Currie et al
Philip B Miner
Expert Opinion on Pharmacotherapy
|
January 30, 2018
Efficacy and safety of plecanatide in treating constipation predominant irritable bowel syndrome
Philip B Miner
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 5, 2019
Effect of Treatment on the Risk of Viral Infections in Inflammatory Bowel Disease
Philip B Miner
Gastroenterology
|
February 24, 2004
Economic and personal impact of fecal and urinary incontinence
Philip B Miner
Gastrointestinal Endoscopy Clinics of North America
|
September 14, 2014
Evaluation of esophageal sensation
Salman Nusrat, Philip B Miner
Page
of 4